nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP3A7—Dexamethasone—psoriatic arthritis	0.0819	0.137	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0819	0.137	CbGbCtD
Iloperidone—CYP2E1—Dexamethasone—psoriatic arthritis	0.0791	0.132	CbGbCtD
Iloperidone—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0634	0.106	CbGbCtD
Iloperidone—CYP3A5—Dexamethasone—psoriatic arthritis	0.0615	0.103	CbGbCtD
Iloperidone—CYP3A4—Triamcinolone—psoriatic arthritis	0.048	0.0803	CbGbCtD
Iloperidone—CYP3A4—Betamethasone—psoriatic arthritis	0.0412	0.0689	CbGbCtD
Iloperidone—CYP3A4—Prednisolone—psoriatic arthritis	0.0407	0.068	CbGbCtD
Iloperidone—CYP3A4—Prednisone—psoriatic arthritis	0.0384	0.0642	CbGbCtD
Iloperidone—CYP2D6—Dexamethasone—psoriatic arthritis	0.0377	0.063	CbGbCtD
Iloperidone—CYP3A4—Dexamethasone—psoriatic arthritis	0.024	0.0401	CbGbCtD
Iloperidone—Delusion—Prednisone—psoriatic arthritis	0.00298	0.00742	CcSEcCtD
Iloperidone—Mania—Prednisone—psoriatic arthritis	0.0029	0.00722	CcSEcCtD
Iloperidone—Cataract—Triamcinolone—psoriatic arthritis	0.00281	0.00698	CcSEcCtD
Iloperidone—Amenorrhoea—Betamethasone—psoriatic arthritis	0.00276	0.00686	CcSEcCtD
Iloperidone—Amenorrhoea—Dexamethasone—psoriatic arthritis	0.00276	0.00686	CcSEcCtD
Iloperidone—Fluid retention—Prednisolone—psoriatic arthritis	0.00276	0.00686	CcSEcCtD
Iloperidone—Endocrine disorder—Prednisone—psoriatic arthritis	0.00255	0.00634	CcSEcCtD
Iloperidone—Cataract—Betamethasone—psoriatic arthritis	0.00255	0.00634	CcSEcCtD
Iloperidone—Cataract—Dexamethasone—psoriatic arthritis	0.00255	0.00634	CcSEcCtD
Iloperidone—Fluid retention—Triamcinolone—psoriatic arthritis	0.00254	0.00631	CcSEcCtD
Iloperidone—Fluid retention—Methylprednisolone—psoriatic arthritis	0.00253	0.0063	CcSEcCtD
Iloperidone—Delirium—Prednisone—psoriatic arthritis	0.00246	0.00611	CcSEcCtD
Iloperidone—Amenorrhoea—Prednisone—psoriatic arthritis	0.0024	0.00598	CcSEcCtD
Iloperidone—Fluid retention—Dexamethasone—psoriatic arthritis	0.0023	0.00573	CcSEcCtD
Iloperidone—Fluid retention—Betamethasone—psoriatic arthritis	0.0023	0.00573	CcSEcCtD
Iloperidone—Increased appetite—Prednisolone—psoriatic arthritis	0.00225	0.00558	CcSEcCtD
Iloperidone—Dry eye—Betamethasone—psoriatic arthritis	0.00224	0.00557	CcSEcCtD
Iloperidone—Dry eye—Dexamethasone—psoriatic arthritis	0.00224	0.00557	CcSEcCtD
Iloperidone—Diarrhoea—Auranofin—psoriatic arthritis	0.00223	0.00553	CcSEcCtD
Iloperidone—Cataract—Prednisone—psoriatic arthritis	0.00222	0.00552	CcSEcCtD
Iloperidone—Affect lability—Prednisolone—psoriatic arthritis	0.00208	0.00516	CcSEcCtD
Iloperidone—Increased appetite—Triamcinolone—psoriatic arthritis	0.00207	0.00514	CcSEcCtD
Iloperidone—Amnesia—Methylprednisolone—psoriatic arthritis	0.00206	0.00512	CcSEcCtD
Iloperidone—Increased appetite—Methylprednisolone—psoriatic arthritis	0.00206	0.00512	CcSEcCtD
Iloperidone—Rash—Auranofin—psoriatic arthritis	0.00205	0.0051	CcSEcCtD
Iloperidone—Dermatitis—Auranofin—psoriatic arthritis	0.00205	0.00509	CcSEcCtD
Iloperidone—Fluid retention—Prednisone—psoriatic arthritis	0.00201	0.00499	CcSEcCtD
Iloperidone—Mood swings—Prednisolone—psoriatic arthritis	0.002	0.00497	CcSEcCtD
Iloperidone—Cardiac failure—Methylprednisolone—psoriatic arthritis	0.00198	0.00493	CcSEcCtD
Iloperidone—Musculoskeletal stiffness—Methotrexate—psoriatic arthritis	0.00197	0.00489	CcSEcCtD
Iloperidone—Nausea—Auranofin—psoriatic arthritis	0.00193	0.0048	CcSEcCtD
Iloperidone—Affect lability—Triamcinolone—psoriatic arthritis	0.00191	0.00475	CcSEcCtD
Iloperidone—Affect lability—Methylprednisolone—psoriatic arthritis	0.00191	0.00474	CcSEcCtD
Iloperidone—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00189	0.0047	CcSEcCtD
Iloperidone—Increased appetite—Betamethasone—psoriatic arthritis	0.00187	0.00466	CcSEcCtD
Iloperidone—Increased appetite—Dexamethasone—psoriatic arthritis	0.00187	0.00466	CcSEcCtD
Iloperidone—Mood swings—Triamcinolone—psoriatic arthritis	0.00184	0.00457	CcSEcCtD
Iloperidone—Mood swings—Methylprednisolone—psoriatic arthritis	0.00183	0.00456	CcSEcCtD
Iloperidone—Cardiac failure—Dexamethasone—psoriatic arthritis	0.0018	0.00449	CcSEcCtD
Iloperidone—Cardiac failure—Betamethasone—psoriatic arthritis	0.0018	0.00449	CcSEcCtD
Iloperidone—Lethargy—Betamethasone—psoriatic arthritis	0.0018	0.00447	CcSEcCtD
Iloperidone—Lethargy—Dexamethasone—psoriatic arthritis	0.0018	0.00447	CcSEcCtD
Iloperidone—Breast disorder—Methylprednisolone—psoriatic arthritis	0.00175	0.00435	CcSEcCtD
Iloperidone—Affect lability—Betamethasone—psoriatic arthritis	0.00173	0.00431	CcSEcCtD
Iloperidone—Affect lability—Dexamethasone—psoriatic arthritis	0.00173	0.00431	CcSEcCtD
Iloperidone—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00172	0.00428	CcSEcCtD
Iloperidone—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00172	0.00428	CcSEcCtD
Iloperidone—Asthma—Triamcinolone—psoriatic arthritis	0.00168	0.00417	CcSEcCtD
Iloperidone—Mood swings—Dexamethasone—psoriatic arthritis	0.00167	0.00415	CcSEcCtD
Iloperidone—Mood swings—Betamethasone—psoriatic arthritis	0.00167	0.00415	CcSEcCtD
Iloperidone—Weight increased—Prednisolone—psoriatic arthritis	0.00166	0.00413	CcSEcCtD
Iloperidone—Increased appetite—Prednisone—psoriatic arthritis	0.00163	0.00406	CcSEcCtD
Iloperidone—Amnesia—Prednisone—psoriatic arthritis	0.00163	0.00406	CcSEcCtD
Iloperidone—Hypokalaemia—Betamethasone—psoriatic arthritis	0.0016	0.00398	CcSEcCtD
Iloperidone—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.0016	0.00398	CcSEcCtD
Iloperidone—Mouth ulceration—Methotrexate—psoriatic arthritis	0.0016	0.00397	CcSEcCtD
Iloperidone—Conjunctivitis—Prednisolone—psoriatic arthritis	0.00158	0.00393	CcSEcCtD
Iloperidone—Gynaecomastia—Methotrexate—psoriatic arthritis	0.00158	0.00393	CcSEcCtD
Iloperidone—Cardiac failure—Prednisone—psoriatic arthritis	0.00157	0.00391	CcSEcCtD
Iloperidone—Lethargy—Prednisone—psoriatic arthritis	0.00156	0.00389	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00156	0.00388	CcSEcCtD
Iloperidone—Weight increased—Triamcinolone—psoriatic arthritis	0.00153	0.00379	CcSEcCtD
Iloperidone—Weight increased—Methylprednisolone—psoriatic arthritis	0.00152	0.00379	CcSEcCtD
Iloperidone—Affect lability—Prednisone—psoriatic arthritis	0.00151	0.00375	CcSEcCtD
Iloperidone—Psychotic disorder—Prednisone—psoriatic arthritis	0.0015	0.00372	CcSEcCtD
Iloperidone—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00145	0.00361	CcSEcCtD
Iloperidone—Mood swings—Prednisone—psoriatic arthritis	0.00145	0.00361	CcSEcCtD
Iloperidone—Epistaxis—Triamcinolone—psoriatic arthritis	0.00141	0.00351	CcSEcCtD
Iloperidone—Hypokalaemia—Prednisone—psoriatic arthritis	0.0014	0.00347	CcSEcCtD
Iloperidone—Renal failure acute—Methotrexate—psoriatic arthritis	0.00139	0.00345	CcSEcCtD
Iloperidone—Weight increased—Dexamethasone—psoriatic arthritis	0.00138	0.00344	CcSEcCtD
Iloperidone—Weight increased—Betamethasone—psoriatic arthritis	0.00138	0.00344	CcSEcCtD
Iloperidone—Weight decreased—Dexamethasone—psoriatic arthritis	0.00138	0.00342	CcSEcCtD
Iloperidone—Weight decreased—Betamethasone—psoriatic arthritis	0.00138	0.00342	CcSEcCtD
Iloperidone—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00132	0.00328	CcSEcCtD
Iloperidone—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00132	0.00328	CcSEcCtD
Iloperidone—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00132	0.00327	CcSEcCtD
Iloperidone—Lethargy—Methotrexate—psoriatic arthritis	0.00131	0.00325	CcSEcCtD
Iloperidone—Arrhythmia—Prednisolone—psoriatic arthritis	0.0013	0.00324	CcSEcCtD
Iloperidone—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00125	0.00311	CcSEcCtD
Iloperidone—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00124	0.00309	CcSEcCtD
Iloperidone—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00122	0.00303	CcSEcCtD
Iloperidone—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00122	0.00302	CcSEcCtD
Iloperidone—Mood swings—Methotrexate—psoriatic arthritis	0.00121	0.00302	CcSEcCtD
Iloperidone—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00121	0.003	CcSEcCtD
Iloperidone—Weight increased—Prednisone—psoriatic arthritis	0.00121	0.003	CcSEcCtD
Iloperidone—Arrhythmia—Triamcinolone—psoriatic arthritis	0.0012	0.00298	CcSEcCtD
Iloperidone—Weight decreased—Prednisone—psoriatic arthritis	0.0012	0.00298	CcSEcCtD
Iloperidone—Vision blurred—Prednisolone—psoriatic arthritis	0.0012	0.00298	CcSEcCtD
Iloperidone—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.0012	0.00298	CcSEcCtD
Iloperidone—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00117	0.00292	CcSEcCtD
Iloperidone—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00117	0.0029	CcSEcCtD
Iloperidone—Breast disorder—Methotrexate—psoriatic arthritis	0.00116	0.00288	CcSEcCtD
Iloperidone—Vertigo—Prednisolone—psoriatic arthritis	0.00114	0.00284	CcSEcCtD
Iloperidone—Eye disorder—Dexamethasone—psoriatic arthritis	0.00114	0.00283	CcSEcCtD
Iloperidone—Eye disorder—Betamethasone—psoriatic arthritis	0.00114	0.00283	CcSEcCtD
Iloperidone—Asthma—Methotrexate—psoriatic arthritis	0.00111	0.00275	CcSEcCtD
Iloperidone—Angiopathy—Dexamethasone—psoriatic arthritis	0.0011	0.00275	CcSEcCtD
Iloperidone—Angiopathy—Betamethasone—psoriatic arthritis	0.0011	0.00275	CcSEcCtD
Iloperidone—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00109	0.00271	CcSEcCtD
Iloperidone—Arrhythmia—Betamethasone—psoriatic arthritis	0.00109	0.00271	CcSEcCtD
Iloperidone—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00106	0.00264	CcSEcCtD
Iloperidone—Vertigo—Triamcinolone—psoriatic arthritis	0.00105	0.00261	CcSEcCtD
Iloperidone—Vertigo—Methylprednisolone—psoriatic arthritis	0.00105	0.0026	CcSEcCtD
Iloperidone—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00104	0.00259	CcSEcCtD
Iloperidone—Oedema—Prednisolone—psoriatic arthritis	0.00104	0.00258	CcSEcCtD
Iloperidone—Dysuria—Methotrexate—psoriatic arthritis	0.00104	0.00258	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00103	0.00256	CcSEcCtD
Iloperidone—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00102	0.00254	CcSEcCtD
Iloperidone—Tachycardia—Prednisolone—psoriatic arthritis	0.00101	0.00252	CcSEcCtD
Iloperidone—Myalgia—Triamcinolone—psoriatic arthritis	0.000995	0.00247	CcSEcCtD
Iloperidone—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000993	0.00247	CcSEcCtD
Iloperidone—Myalgia—Methylprednisolone—psoriatic arthritis	0.000993	0.00247	CcSEcCtD
Iloperidone—Eye disorder—Prednisone—psoriatic arthritis	0.000991	0.00246	CcSEcCtD
Iloperidone—Dry mouth—Triamcinolone—psoriatic arthritis	0.000973	0.00242	CcSEcCtD
Iloperidone—Stomatitis—Methotrexate—psoriatic arthritis	0.000962	0.00239	CcSEcCtD
Iloperidone—Angiopathy—Prednisone—psoriatic arthritis	0.000962	0.00239	CcSEcCtD
Iloperidone—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00096	0.00239	CcSEcCtD
Iloperidone—Confusional state—Methylprednisolone—psoriatic arthritis	0.000959	0.00239	CcSEcCtD
Iloperidone—Oedema—Triamcinolone—psoriatic arthritis	0.000954	0.00237	CcSEcCtD
Iloperidone—Vertigo—Betamethasone—psoriatic arthritis	0.000953	0.00237	CcSEcCtD
Iloperidone—Vertigo—Dexamethasone—psoriatic arthritis	0.000953	0.00237	CcSEcCtD
Iloperidone—Arrhythmia—Prednisone—psoriatic arthritis	0.000948	0.00236	CcSEcCtD
Iloperidone—Infection—Triamcinolone—psoriatic arthritis	0.000947	0.00236	CcSEcCtD
Iloperidone—Infection—Methylprednisolone—psoriatic arthritis	0.000945	0.00235	CcSEcCtD
Iloperidone—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000934	0.00232	CcSEcCtD
Iloperidone—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000933	0.00232	CcSEcCtD
Iloperidone—Epistaxis—Methotrexate—psoriatic arthritis	0.000931	0.00232	CcSEcCtD
Iloperidone—Paraesthesia—Prednisolone—psoriatic arthritis	0.000931	0.00232	CcSEcCtD
Iloperidone—Tachycardia—Triamcinolone—psoriatic arthritis	0.000931	0.00231	CcSEcCtD
Iloperidone—Mental disorder—Prednisone—psoriatic arthritis	0.000929	0.00231	CcSEcCtD
Iloperidone—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000929	0.00231	CcSEcCtD
Iloperidone—Malnutrition—Prednisone—psoriatic arthritis	0.000923	0.0023	CcSEcCtD
Iloperidone—Myalgia—Dexamethasone—psoriatic arthritis	0.000903	0.00224	CcSEcCtD
Iloperidone—Myalgia—Betamethasone—psoriatic arthritis	0.000903	0.00224	CcSEcCtD
Iloperidone—Hypotension—Methylprednisolone—psoriatic arthritis	0.000889	0.00221	CcSEcCtD
Iloperidone—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000875	0.00218	CcSEcCtD
Iloperidone—Vision blurred—Prednisone—psoriatic arthritis	0.00087	0.00216	CcSEcCtD
Iloperidone—Urethral disorder—Methotrexate—psoriatic arthritis	0.000869	0.00216	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000869	0.00216	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000867	0.00216	CcSEcCtD
Iloperidone—Oedema—Betamethasone—psoriatic arthritis	0.000865	0.00215	CcSEcCtD
Iloperidone—Oedema—Dexamethasone—psoriatic arthritis	0.000865	0.00215	CcSEcCtD
Iloperidone—Infection—Dexamethasone—psoriatic arthritis	0.00086	0.00214	CcSEcCtD
Iloperidone—Infection—Betamethasone—psoriatic arthritis	0.00086	0.00214	CcSEcCtD
Iloperidone—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000856	0.00213	CcSEcCtD
Iloperidone—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000855	0.00212	CcSEcCtD
Iloperidone—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000854	0.00212	CcSEcCtD
Iloperidone—Anaemia—Prednisone—psoriatic arthritis	0.000853	0.00212	CcSEcCtD
Iloperidone—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00085	0.00211	CcSEcCtD
Iloperidone—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000849	0.00211	CcSEcCtD
Iloperidone—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000849	0.00211	CcSEcCtD
Iloperidone—Agitation—Prednisone—psoriatic arthritis	0.000848	0.00211	CcSEcCtD
Iloperidone—Tachycardia—Dexamethasone—psoriatic arthritis	0.000844	0.0021	CcSEcCtD
Iloperidone—Tachycardia—Betamethasone—psoriatic arthritis	0.000844	0.0021	CcSEcCtD
Iloperidone—Vertigo—Prednisone—psoriatic arthritis	0.00083	0.00206	CcSEcCtD
Iloperidone—Eye disorder—Methotrexate—psoriatic arthritis	0.000828	0.00206	CcSEcCtD
Iloperidone—Tinnitus—Methotrexate—psoriatic arthritis	0.000826	0.00206	CcSEcCtD
Iloperidone—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000823	0.00205	CcSEcCtD
Iloperidone—Fatigue—Triamcinolone—psoriatic arthritis	0.000822	0.00204	CcSEcCtD
Iloperidone—Fatigue—Methylprednisolone—psoriatic arthritis	0.00082	0.00204	CcSEcCtD
Iloperidone—Hypotension—Betamethasone—psoriatic arthritis	0.000809	0.00201	CcSEcCtD
Iloperidone—Hypotension—Dexamethasone—psoriatic arthritis	0.000809	0.00201	CcSEcCtD
Iloperidone—Angiopathy—Methotrexate—psoriatic arthritis	0.000804	0.002	CcSEcCtD
Iloperidone—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000799	0.00199	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000788	0.00196	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000788	0.00196	CcSEcCtD
Iloperidone—Arthralgia—Prednisone—psoriatic arthritis	0.000786	0.00195	CcSEcCtD
Iloperidone—Myalgia—Prednisone—psoriatic arthritis	0.000786	0.00195	CcSEcCtD
Iloperidone—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000786	0.00195	CcSEcCtD
Iloperidone—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000784	0.00195	CcSEcCtD
Iloperidone—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000777	0.00193	CcSEcCtD
Iloperidone—Paraesthesia—Betamethasone—psoriatic arthritis	0.000777	0.00193	CcSEcCtD
Iloperidone—Mental disorder—Methotrexate—psoriatic arthritis	0.000777	0.00193	CcSEcCtD
Iloperidone—Malnutrition—Methotrexate—psoriatic arthritis	0.000772	0.00192	CcSEcCtD
Iloperidone—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000754	0.00187	CcSEcCtD
Iloperidone—Oedema—Prednisone—psoriatic arthritis	0.000754	0.00187	CcSEcCtD
Iloperidone—Infection—Prednisone—psoriatic arthritis	0.000749	0.00186	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000747	0.00186	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000747	0.00186	CcSEcCtD
Iloperidone—Fatigue—Dexamethasone—psoriatic arthritis	0.000746	0.00186	CcSEcCtD
Iloperidone—Fatigue—Betamethasone—psoriatic arthritis	0.000746	0.00186	CcSEcCtD
Iloperidone—Nervous system disorder—Prednisone—psoriatic arthritis	0.000739	0.00184	CcSEcCtD
Iloperidone—Tachycardia—Prednisone—psoriatic arthritis	0.000735	0.00183	CcSEcCtD
Iloperidone—Vision blurred—Methotrexate—psoriatic arthritis	0.000727	0.00181	CcSEcCtD
Iloperidone—Anaemia—Methotrexate—psoriatic arthritis	0.000713	0.00177	CcSEcCtD
Iloperidone—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000713	0.00177	CcSEcCtD
Iloperidone—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000713	0.00177	CcSEcCtD
Iloperidone—Vertigo—Methotrexate—psoriatic arthritis	0.000693	0.00172	CcSEcCtD
Iloperidone—Leukopenia—Methotrexate—psoriatic arthritis	0.000691	0.00172	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000687	0.00171	CcSEcCtD
Iloperidone—Dizziness—Prednisolone—psoriatic arthritis	0.000686	0.00171	CcSEcCtD
Iloperidone—Asthenia—Triamcinolone—psoriatic arthritis	0.000684	0.0017	CcSEcCtD
Iloperidone—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000684	0.0017	CcSEcCtD
Iloperidone—Body temperature increased—Betamethasone—psoriatic arthritis	0.000684	0.0017	CcSEcCtD
Iloperidone—Asthenia—Methylprednisolone—psoriatic arthritis	0.000683	0.0017	CcSEcCtD
Iloperidone—Paraesthesia—Prednisone—psoriatic arthritis	0.000677	0.00168	CcSEcCtD
Iloperidone—Myalgia—Methotrexate—psoriatic arthritis	0.000657	0.00163	CcSEcCtD
Iloperidone—Arthralgia—Methotrexate—psoriatic arthritis	0.000657	0.00163	CcSEcCtD
Iloperidone—Rash—Prednisolone—psoriatic arthritis	0.000654	0.00163	CcSEcCtD
Iloperidone—Dermatitis—Prednisolone—psoriatic arthritis	0.000653	0.00162	CcSEcCtD
Iloperidone—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000651	0.00162	CcSEcCtD
Iloperidone—Fatigue—Prednisone—psoriatic arthritis	0.00065	0.00162	CcSEcCtD
Iloperidone—Confusional state—Methotrexate—psoriatic arthritis	0.000635	0.00158	CcSEcCtD
Iloperidone—Dizziness—Triamcinolone—psoriatic arthritis	0.000631	0.00157	CcSEcCtD
Iloperidone—Dizziness—Methylprednisolone—psoriatic arthritis	0.000629	0.00156	CcSEcCtD
Iloperidone—Infection—Methotrexate—psoriatic arthritis	0.000626	0.00156	CcSEcCtD
Iloperidone—Feeling abnormal—Prednisone—psoriatic arthritis	0.000621	0.00154	CcSEcCtD
Iloperidone—Asthenia—Dexamethasone—psoriatic arthritis	0.000621	0.00154	CcSEcCtD
Iloperidone—Asthenia—Betamethasone—psoriatic arthritis	0.000621	0.00154	CcSEcCtD
Iloperidone—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000618	0.00154	CcSEcCtD
Iloperidone—Nausea—Prednisolone—psoriatic arthritis	0.000616	0.00153	CcSEcCtD
Iloperidone—Rash—Triamcinolone—psoriatic arthritis	0.000601	0.0015	CcSEcCtD
Iloperidone—Dermatitis—Triamcinolone—psoriatic arthritis	0.000601	0.00149	CcSEcCtD
Iloperidone—Rash—Methylprednisolone—psoriatic arthritis	0.0006	0.00149	CcSEcCtD
Iloperidone—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000599	0.00149	CcSEcCtD
Iloperidone—Body temperature increased—Prednisone—psoriatic arthritis	0.000596	0.00148	CcSEcCtD
Iloperidone—Diarrhoea—Betamethasone—psoriatic arthritis	0.000592	0.00147	CcSEcCtD
Iloperidone—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000592	0.00147	CcSEcCtD
Iloperidone—Hypotension—Methotrexate—psoriatic arthritis	0.000588	0.00146	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000574	0.00143	CcSEcCtD
Iloperidone—Dizziness—Dexamethasone—psoriatic arthritis	0.000572	0.00142	CcSEcCtD
Iloperidone—Dizziness—Betamethasone—psoriatic arthritis	0.000572	0.00142	CcSEcCtD
Iloperidone—Nausea—Triamcinolone—psoriatic arthritis	0.000566	0.00141	CcSEcCtD
Iloperidone—Paraesthesia—Methotrexate—psoriatic arthritis	0.000565	0.00141	CcSEcCtD
Iloperidone—Nausea—Methylprednisolone—psoriatic arthritis	0.000565	0.00141	CcSEcCtD
Iloperidone—Dyspnoea—Methotrexate—psoriatic arthritis	0.000561	0.0014	CcSEcCtD
Iloperidone—Somnolence—Methotrexate—psoriatic arthritis	0.00056	0.00139	CcSEcCtD
Iloperidone—Rash—Betamethasone—psoriatic arthritis	0.000546	0.00136	CcSEcCtD
Iloperidone—Rash—Dexamethasone—psoriatic arthritis	0.000546	0.00136	CcSEcCtD
Iloperidone—Dermatitis—Dexamethasone—psoriatic arthritis	0.000545	0.00136	CcSEcCtD
Iloperidone—Dermatitis—Betamethasone—psoriatic arthritis	0.000545	0.00136	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000544	0.00135	CcSEcCtD
Iloperidone—Fatigue—Methotrexate—psoriatic arthritis	0.000543	0.00135	CcSEcCtD
Iloperidone—Asthenia—Prednisone—psoriatic arthritis	0.000541	0.00134	CcSEcCtD
Iloperidone—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000519	0.00129	CcSEcCtD
Iloperidone—Diarrhoea—Prednisone—psoriatic arthritis	0.000516	0.00128	CcSEcCtD
Iloperidone—Nausea—Betamethasone—psoriatic arthritis	0.000514	0.00128	CcSEcCtD
Iloperidone—Nausea—Dexamethasone—psoriatic arthritis	0.000514	0.00128	CcSEcCtD
Iloperidone—Dizziness—Prednisone—psoriatic arthritis	0.000498	0.00124	CcSEcCtD
Iloperidone—Body temperature increased—Methotrexate—psoriatic arthritis	0.000498	0.00124	CcSEcCtD
Iloperidone—Rash—Prednisone—psoriatic arthritis	0.000475	0.00118	CcSEcCtD
Iloperidone—Dermatitis—Prednisone—psoriatic arthritis	0.000475	0.00118	CcSEcCtD
Iloperidone—Asthenia—Methotrexate—psoriatic arthritis	0.000452	0.00112	CcSEcCtD
Iloperidone—Nausea—Prednisone—psoriatic arthritis	0.000448	0.00111	CcSEcCtD
Iloperidone—Diarrhoea—Methotrexate—psoriatic arthritis	0.000431	0.00107	CcSEcCtD
Iloperidone—Dizziness—Methotrexate—psoriatic arthritis	0.000416	0.00104	CcSEcCtD
Iloperidone—Rash—Methotrexate—psoriatic arthritis	0.000397	0.000987	CcSEcCtD
Iloperidone—Dermatitis—Methotrexate—psoriatic arthritis	0.000397	0.000986	CcSEcCtD
Iloperidone—Nausea—Methotrexate—psoriatic arthritis	0.000374	0.00093	CcSEcCtD
